259 related articles for article (PubMed ID: 21494805)
1. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.
Rybaltowski M; Suzuki Y; Mogami H; Chlebinska I; Brzoska T; Tanaka A; Banno F; Miyata T; Urano T
Pflugers Arch; 2011 Jun; 461(6):623-33. PubMed ID: 21494805
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.
Bonnefoy A; Daenens K; Feys HB; De Vos R; Vandervoort P; Vermylen J; Lawler J; Hoylaerts MF
Blood; 2006 Feb; 107(3):955-64. PubMed ID: 16204318
[TBL] [Abstract][Full Text] [Related]
3. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
Bao J; Xiao J; Mao Y; Zheng XL
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
[TBL] [Abstract][Full Text] [Related]
4. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.
Dong JF; Moake JL; Bernardo A; Fujikawa K; Ball C; Nolasco L; López JA; Cruz MA
J Biol Chem; 2003 Aug; 278(32):29633-9. PubMed ID: 12775718
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
Dong JF; Moake JL; Nolasco L; Bernardo A; Arceneaux W; Shrimpton CN; Schade AJ; McIntire LV; Fujikawa K; López JA
Blood; 2002 Dec; 100(12):4033-9. PubMed ID: 12393397
[TBL] [Abstract][Full Text] [Related]
6. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.
Padilla A; Moake JL; Bernardo A; Ball C; Wang Y; Arya M; Nolasco L; Turner N; Berndt MC; Anvari B; López JA; Dong JF
Blood; 2004 Mar; 103(6):2150-6. PubMed ID: 14630802
[TBL] [Abstract][Full Text] [Related]
7. Unwinding the von Willebrand factor strings puzzle.
De Ceunynck K; De Meyer SF; Vanhoorelbeke K
Blood; 2013 Jan; 121(2):270-7. PubMed ID: 23093621
[TBL] [Abstract][Full Text] [Related]
8. Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin.
Chauhan AK; Goerge T; Schneider SW; Wagner DD
J Thromb Haemost; 2007 Mar; 5(3):583-9. PubMed ID: 17166247
[TBL] [Abstract][Full Text] [Related]
9. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
Reiter RA; Knöbl P; Varadi K; Turecek PL
Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
[TBL] [Abstract][Full Text] [Related]
10. Endothelial CD40 Mediates Microvascular von Willebrand Factor-Dependent Platelet Adhesion Inducing Inflammatory Venothrombosis in ADAMTS13 Knockout Mice.
Tahir S; Wagner AH; Dietzel S; Mannell H; Pircher J; Weckbach LT; Hecker M; Pohl U
Thromb Haemost; 2020 Mar; 120(3):466-476. PubMed ID: 32135568
[TBL] [Abstract][Full Text] [Related]
11. Systemic antithrombotic effects of ADAMTS13.
Chauhan AK; Motto DG; Lamb CB; Bergmeier W; Dockal M; Plaimauer B; Scheiflinger F; Ginsburg D; Wagner DD
J Exp Med; 2006 Mar; 203(3):767-76. PubMed ID: 16533881
[TBL] [Abstract][Full Text] [Related]
12. Single particle tracking of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type-1 repeats) molecules on endothelial von Willebrand factor strings.
De Ceunynck K; Rocha S; De Meyer SF; Sadler JE; Uji-i H; Deckmyn H; Hofkens J; Vanhoorelbeke K
J Biol Chem; 2014 Mar; 289(13):8903-15. PubMed ID: 24550384
[TBL] [Abstract][Full Text] [Related]
13. Plasma Peptidylarginine Deiminase IV Promotes VWF-Platelet String Formation and Accelerates Thrombosis After Vessel Injury.
Sorvillo N; Mizurini DM; Coxon C; Martinod K; Tilvawala R; Cherpokova D; Salinger AJ; Seward RJ; Staudinger C; Weerapana E; Shapiro NI; Costello CE; Thompson PR; Wagner DD
Circ Res; 2019 Aug; 125(5):507-519. PubMed ID: 31248335
[TBL] [Abstract][Full Text] [Related]
14. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
15. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL
Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569
[TBL] [Abstract][Full Text] [Related]
16. Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.
Popa M; Tahir S; Elrod J; Kim SH; Leuschner F; Kessler T; Bugert P; Pohl U; Wagner AH; Hecker M
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5556-E5565. PubMed ID: 29793936
[TBL] [Abstract][Full Text] [Related]
17. Numerical study of ultra-large von Willebrand factor multimers in coagulopathy.
Rahmati N; Keshavarz Motamed P; Maftoon N
Biomech Model Mechanobiol; 2024 Jun; 23(3):737-756. PubMed ID: 38217745
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.
Crawley JT; de Groot R; Xiang Y; Luken BM; Lane DA
Blood; 2011 Sep; 118(12):3212-21. PubMed ID: 21715306
[TBL] [Abstract][Full Text] [Related]
19. Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.
Rayes J; Hollestelle MJ; Legendre P; Marx I; de Groot PG; Christophe OD; Lenting PJ; Denis CV
Blood; 2010 Jun; 115(23):4870-7. PubMed ID: 20200350
[TBL] [Abstract][Full Text] [Related]
20. Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network.
Barg A; Ossig R; Goerge T; Schneider MF; Schillers H; Oberleithner H; Schneider SW
Thromb Haemost; 2007 Apr; 97(4):514-26. PubMed ID: 17393012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
